Literature DB >> 24496499

Searching for Grendel: origin and global spread of the C9ORF72 repeat expansion.

Hannah A Pliner1, David M Mann, Bryan J Traynor.   

Abstract

Recent advances are uncovering more and more of the genetic architecture underlying amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative condition that affects ~6,000 Americans annually. Chief among these was the discovery that a large repeat expansion in the C9ORF72 gene is responsible for an unprecedented portion of familial and sporadic ALS cases. Much has been published on how this expansion disrupts neuronal homeostasis and how gene-based therapy might be an effective treatment in the future. Nevertheless, it is instructive to look back at the origins of this important mutation. In this opinion piece, we attempt to answer three key questions concerning C9ORF72. First, how many times did the expansion occur throughout human history? Second, how old is the expansion? And finally and perhaps most importantly, how did the expansion spread throughout Europe? We speculate that the expansion occurred only once in the past, that this event took place in the Finnish population and that the Vikings and their descendants were responsible for disseminating this mutation throughout the rest of the continent.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24496499      PMCID: PMC4545603          DOI: 10.1007/s00401-014-1250-x

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  37 in total

1.  Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS.

Authors:  Mariely DeJesus-Hernandez; Ian R Mackenzie; Bradley F Boeve; Adam L Boxer; Matt Baker; Nicola J Rutherford; Alexandra M Nicholson; NiCole A Finch; Heather Flynn; Jennifer Adamson; Naomi Kouri; Aleksandra Wojtas; Pheth Sengdy; Ging-Yuek R Hsiung; Anna Karydas; William W Seeley; Keith A Josephs; Giovanni Coppola; Daniel H Geschwind; Zbigniew K Wszolek; Howard Feldman; David S Knopman; Ronald C Petersen; Bruce L Miller; Dennis W Dickson; Kevin B Boylan; Neill R Graff-Radford; Rosa Rademakers
Journal:  Neuron       Date:  2011-09-21       Impact factor: 17.173

2.  Analysis of C9orf72 repeat expansion in 563 Japanese patients with amyotrophic lateral sclerosis.

Authors:  Kotaro Ogaki; Yuanzhe Li; Naoki Atsuta; Hiroyuki Tomiyama; Manabu Funayama; Hazuki Watanabe; Ryoichi Nakamura; Hideo Yoshino; Seiji Yato; Asako Tamura; Yutaka Naito; Akira Taniguchi; Koji Fujita; Yuishin Izumi; Ryuji Kaji; Nobutaka Hattori; Gen Sobue
Journal:  Neurobiol Aging       Date:  2012-06-21       Impact factor: 4.673

Review 3.  Ethnic variation in the incidence of ALS: a systematic review.

Authors:  Simon Cronin; Orla Hardiman; Bryan J Traynor
Journal:  Neurology       Date:  2007-03-27       Impact factor: 9.910

4.  Road to the chromosome 9p-linked ALS/FTD locus.

Authors:  Bryan J Traynor
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-04       Impact factor: 10.154

5.  C9ORF72 repeat expansion in amyotrophic lateral sclerosis in the Kii peninsula of Japan.

Authors:  Hiroyuki Ishiura; Yuji Takahashi; Jun Mitsui; Sohei Yoshida; Tameko Kihira; Yasumasa Kokubo; Shigeki Kuzuhara; Laura P W Ranum; Tomoko Tamaoki; Yaeko Ichikawa; Hidetoshi Date; Jun Goto; Shoji Tsuji
Journal:  Arch Neurol       Date:  2012-09

6.  Evidence of a founder effect in families with frontotemporal dementia that harbor the tau +16 splice mutation.

Authors:  Stuart Pickering-Brown; Matt Baker; Thomas Bird; John Trojanowski; Virginia Lee; Huw Morris; Martin Rossor; John C Janssen; David Neary; David Craufurd; Anna Richardson; Julie Snowden; John Hardy; David Mann; Mike Hutton
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2004-02-15       Impact factor: 3.568

7.  Spinocerebellar ataxia type 8: molecular genetic comparisons and haplotype analysis of 37 families with ataxia.

Authors:  Yoshio Ikeda; Joline C Dalton; Melinda L Moseley; Kathy L Gardner; Thomas D Bird; Tetsuo Ashizawa; William K Seltzer; Massimo Pandolfo; Aubrey Milunsky; Nicholas T Potter; Mikio Shoji; John B Vincent; John W Day; Laura P W Ranum
Journal:  Am J Hum Genet       Date:  2004-05-19       Impact factor: 11.025

8.  RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention.

Authors:  Christopher J Donnelly; Ping-Wu Zhang; Jacqueline T Pham; Aaron R Haeusler; Aaron R Heusler; Nipun A Mistry; Svetlana Vidensky; Elizabeth L Daley; Erin M Poth; Benjamin Hoover; Daniel M Fines; Nicholas Maragakis; Pentti J Tienari; Leonard Petrucelli; Bryan J Traynor; Jiou Wang; Frank Rigo; C Frank Bennett; Seth Blackshaw; Rita Sattler; Jeffrey D Rothstein
Journal:  Neuron       Date:  2013-10-16       Impact factor: 17.173

9.  The C9ORF72 expansion mutation is a common cause of ALS+/-FTD in Europe and has a single founder.

Authors:  Bradley N Smith; Stephen Newhouse; Aleksey Shatunov; Caroline Vance; Simon Topp; Lauren Johnson; Jack Miller; Younbok Lee; Claire Troakes; Kirsten M Scott; Ashley Jones; Ian Gray; Jamie Wright; Tibor Hortobágyi; Safa Al-Sarraj; Boris Rogelj; John Powell; Michelle Lupton; Simon Lovestone; Peter C Sapp; Markus Weber; Peter J Nestor; Helenius J Schelhaas; Anneloor Alm Ten Asbroek; Vincenzo Silani; Cinzia Gellera; Franco Taroni; Nicola Ticozzi; Leonard Van den Berg; Jan Veldink; Phillip Van Damme; Wim Robberecht; Pamela J Shaw; Janine Kirby; Hardev Pall; Karen E Morrison; Alex Morris; Jacqueline de Belleroche; J M B Vianney de Jong; Frank Baas; Peter M Andersen; John Landers; Robert H Brown; Michael E Weale; Ammar Al-Chalabi; Christopher E Shaw
Journal:  Eur J Hum Genet       Date:  2012-06-13       Impact factor: 4.246

10.  Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72.

Authors:  Johnathan Cooper-Knock; Christopher Hewitt; J Robin Highley; Alice Brockington; Antonio Milano; Somai Man; Joanne Martindale; Judith Hartley; Theresa Walsh; Catherine Gelsthorpe; Lynne Baxter; Gillian Forster; Melanie Fox; Joanna Bury; Kin Mok; Christopher J McDermott; Bryan J Traynor; Janine Kirby; Stephen B Wharton; Paul G Ince; John Hardy; Pamela J Shaw
Journal:  Brain       Date:  2012-03       Impact factor: 13.501

View more
  13 in total

1.  Jump from pre-mutation to pathologic expansion in C9orf72.

Authors:  Zhengrui Xi; Marka van Blitterswijk; Ming Zhang; Philip McGoldrick; Jesse R McLean; Yana Yunusova; Erin Knock; Danielle Moreno; Christine Sato; Paul M McKeever; Raphael Schneider; Julia Keith; Nicolae Petrescu; Paul Fraser; Maria Carmela Tartaglia; Matthew C Baker; Neill R Graff-Radford; Kevin B Boylan; Dennis W Dickson; Ian R Mackenzie; Rosa Rademakers; Janice Robertson; Lorne Zinman; Ekaterina Rogaeva
Journal:  Am J Hum Genet       Date:  2015-05-21       Impact factor: 11.025

Review 2.  The imaging signature of C9orf72 hexanucleotide repeat expansions: implications for clinical trials and therapy development.

Authors:  Stacey Li Hi Shing; Mary Clare McKenna; We Fong Siah; Rangariroyashe H Chipika; Orla Hardiman; Peter Bede
Journal:  Brain Imaging Behav       Date:  2021-01-05       Impact factor: 3.978

Review 3.  The Genetics of C9orf72 Expansions.

Authors:  Ilse Gijselinck; Marc Cruts; Christine Van Broeckhoven
Journal:  Cold Spring Harb Perspect Med       Date:  2018-04-02       Impact factor: 6.915

4.  No abnormal hexanucleotide repeat expansion of C9ORF72 in Japanese schizophrenia patients.

Authors:  Yuta Yoshino; Yoko Mori; Shinichiro Ochi; Shusuke Numata; Takashi Ishimaru; Kiyohiro Yamazaki; Tetsuro Ohmori; Shu-ichi Ueno
Journal:  J Neural Transm (Vienna)       Date:  2014-08-13       Impact factor: 3.575

5.  Hexanucleotide Repeat Expansion in C9ORF72 Is Not Detected in the Treatment-Resistant Schizophrenia Patients of Chinese Han.

Authors:  Xijia Xu; Shiping Xie; Xiaomeng Shi; Jie Lv; Xiaowei Tang; Xiaolan Wang; Shuiping Lu; Mingzhong Wang; Xiaobing Zhang; Jing Sun; Hui Yao
Journal:  PLoS One       Date:  2015-12-21       Impact factor: 3.240

6.  Prevalence of amyotrophic lateral sclerosis in Latium region, Italy.

Authors:  Maria Puopolo; Ilaria Bacigalupo; Paola Piscopo; Eleonora Lacorte; Alessandra Di Pucchio; Marialaura Santarelli; Maurizio Inghilleri; Antonio Petrucci; Mario Sabatelli; Nicola Vanacore
Journal:  Brain Behav       Date:  2021-10-30       Impact factor: 2.708

Review 7.  FRONTotemporal dementia Incidence European Research Study-FRONTIERS: Rationale and design.

Authors:  Barbara Borroni; Caroline Graff; Orla Hardiman; Albert C Ludolph; Fermin Moreno; Markus Otto; Marco Piccininni; Anne M Remes; James B Rowe; Harro Seelaar; Elka Stefanova; Latchezar Traykov; Giancarlo Logroscino
Journal:  Alzheimers Dement       Date:  2021-08-02       Impact factor: 16.655

8.  Screening a UK amyotrophic lateral sclerosis cohort provides evidence of multiple origins of the C9orf72 expansion.

Authors:  Pietro Fratta; James M Polke; Jia Newcombe; Sarah Mizielinska; Tammaryn Lashley; Mark Poulter; Jon Beck; Elisavet Preza; Anny Devoy; Katie Sidle; Robin Howard; Andrea Malaspina; Richard W Orrell; Jan Clarke; Ching-Hua Lu; Kin Mok; Toby Collins; Maryam Shoaii; Tina Nanji; Selina Wray; Gary Adamson; Alan Pittman; Alan E Renton; Bryan J Traynor; Mary G Sweeney; Tamas Revesz; Henry Houlden; Simon Mead; Adrian M Isaacs; Elizabeth M C Fisher
Journal:  Neurobiol Aging       Date:  2014-08-01       Impact factor: 4.673

9.  Incidence of pathogenic, likely pathogenic, and uncertain ALS variants in a clinic cohort.

Authors:  Jennifer Roggenbuck; Marilly Palettas; Leah Vicini; Radha Patel; Adam Quick; Stephen J Kolb
Journal:  Neurol Genet       Date:  2020-01-13

10.  Investigating the Genetic Profile of the Amyotrophic Lateral Sclerosis/Frontotemporal Dementia (ALS-FTD) Continuum in Patients of Diverse Race, Ethnicity and Ancestry.

Authors:  Maysen Mesaros; Steven Lenz; Woobeen Lim; Jordan Brown; Luke Drury; Jennifer Roggenbuck
Journal:  Genes (Basel)       Date:  2021-12-28       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.